These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3486769

  • 1. Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice.
    Sundström E, Jonsson G.
    Eur J Pharmacol; 1986 Mar 18; 122(2):275-8. PubMed ID: 3486769
    [Abstract] [Full Text] [Related]

  • 2. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
    Lydén-Sokolowski A, Larsson BS, Lindquist NG.
    Pharmacol Toxicol; 1988 Aug 18; 63(2):75-80. PubMed ID: 3141911
    [Abstract] [Full Text] [Related]

  • 3. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G, Nwanze E, Luthman J, Sundström E.
    Acta Physiol Scand; 1986 Oct 18; 128(2):187-94. PubMed ID: 3535380
    [Abstract] [Full Text] [Related]

  • 4. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P, Larsson BS, Lindberg BS, Oreland L, Gullberg P, Långström B, Rimland A, Lundqvist H, Malmborg P, Lindquist NG.
    Acta Neurol Scand; 1986 Jul 18; 74(1):10-6. PubMed ID: 3490110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain.
    Pileblad E, Carlsson A.
    Neuropharmacology; 1985 Jul 18; 24(7):689-92. PubMed ID: 3875057
    [Abstract] [Full Text] [Related]

  • 10. Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by the catecholamine uptake inhibitor nomifensine: behavioral analysis in monkeys with partial striatal dopamine depletions.
    Schultz W, Scarnati E, Sundström E, Romo R.
    Neuroscience; 1989 Jul 18; 31(1):219-30. PubMed ID: 2528081
    [Abstract] [Full Text] [Related]

  • 11. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E, Carlsson A.
    Pharmacol Toxicol; 1988 Apr 18; 62(4):213-22. PubMed ID: 3260379
    [Abstract] [Full Text] [Related]

  • 12. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Apr 18; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 13. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR, Kunis DM, Irwin I, Langston JW.
    Neurosci Lett; 1987 Apr 10; 75(3):323-8. PubMed ID: 3495754
    [Abstract] [Full Text] [Related]

  • 14. Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines.
    Martel F, Martins MJ, Azevedo I.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 10; 354(3):305-11. PubMed ID: 8878060
    [Abstract] [Full Text] [Related]

  • 15. Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
    Nakazato T, Akiyama A.
    Brain Res; 1998 Nov 23; 812(1-2):150-6. PubMed ID: 9813295
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Science; 1984 Sep 28; 225(4669):1480-2. PubMed ID: 6332378
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys.
    Palombo E, Porrino LJ, Crane AM, Bankiewicz KS, Kopin IJ, Sokoloff L.
    J Neurochem; 1991 May 28; 56(5):1639-46. PubMed ID: 2013759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.